Werewolf Therapeutics Revenue and Competitors

Boston, MA USA

Location

$128.2M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Werewolf Therapeutics's estimated annual revenue is currently $7.6M per year.(i)
  • Werewolf Therapeutics's estimated revenue per employee is $138,091
  • Werewolf Therapeutics's total funding is $128.2M.
  • Werewolf Therapeutics's current valuation is $246M. (January 2022)

Employee Data

  • Werewolf Therapeutics has 55 Employees.(i)
  • Werewolf Therapeutics grew their employee count by -7% last year.

Werewolf Therapeutics's People

NameTitleEmail/Phone
1
CEO/President/Board MemberReveal Email/Phone
2
VP, Clinical Development OperationsReveal Email/Phone
3
VP Immunology (Immuno-Oncology)Reveal Email/Phone
4
Head Clinical Pharmacology and PharmacometricsReveal Email/Phone
5
VP Program and Portfolio ManagementReveal Email/Phone
6
VP, LegalReveal Email/Phone
7
Director OperationsReveal Email/Phone
8
Chief Technology OfficerReveal Email/Phone
9
Senior Director, Clinical OperationsReveal Email/Phone
10
Senior Director, Financial Planning and AnalysisReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12.7M82-45%$107.3MN/A
#2
$0.2M1-50%N/AN/A
#3
$6.2M4021%N/AN/A
#4
$42.2M2184%$165MN/A
#5
$14.6M94-37%$312.8MN/A
#6
$0.3M2-67%N/AN/A
#7
$235M366-5%$340.9MN/A
#8
$56M289-7%$7.6MN/A
#9
$4.7M6136%N/AN/A
#10
$2M138%N/AN/A
Add Company

What Is Werewolf Therapeutics?

We are an immuno-oncology company advancing a pipeline of next generation, transformative cancer treatments.

keywords:N/A

$128.2M

Total Funding

55

Number of Employees

$7.6M

Revenue (est)

-7%

Employee Growth %

$246M

Valuation

N/A

Accelerator

Werewolf Therapeutics News

2022-04-17 - Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Given Average ...

Werewolf Therapeutics, Inc, a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the...

2022-04-06 - Jazz Pharmaceuticals and Werewolf Therapeutics Announce ...

Werewolf Therapeutics, Inc. is an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the...

2022-04-06 - Werewolf Therapeutics Shares Reverse Course Day After Deal With Jazz Pharmaceuticals

Werewolf Therapeutics Inc. shares fell roughly 19% to $4.71, erasing gains made Thursday after the company said it signed a licensing...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$27M55-62%$281.5M
#2
$8.4M556%N/A
#3
$8.5M5541%N/A
#4
$6.9M5515%N/A
#5
$8.5M550%N/A